ddp4 and glp 1 together Mechanism of action for GIP, GLP-1 analogues DPP4 inhibitors in How does sitagliptin work? DPP-4

Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus

The American Academy of Pediatrics endorsed GLP-1 medications for patients 12 and older with obesity in 2023, legitimizing their use in pediatric weight management

The appetite-suppressing effects become stronger, leading to a significant reduction in hunger and food cravings

Rapid weight loss itself can trigger temporary mood shifts

Moving Beyond Lifestyle Benefits Traditionally, employer-sponsored weight management programs, such as wellness support, gym reimbursement, and nutrition counseling, have been classified as "lifestyle benefits." However, as GLP-1 therapies gain FDA approval for cardiovascular, kidney, metabolic, and sleep-related conditions, treating them as lifestyle benefits ignores their role in preventing high-cost chronic disease and shifts avoidable risk back onto employers